South Korean Pharmaceuticals & Biotech Undervalued over 20% based on DCF

ALTEOGEN

Market Cap: ₩16.1t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Hanmi Pharm

Market Cap: ₩5.1t

A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.

ST PharmLtd

Market Cap: ₩2.5t

Provides manufacturing services for active pharmaceutical ingredient and intermediate.

GC Biopharma

Market Cap: ₩1.4t

A biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.

DongKook Pharmaceutical

Market Cap: ₩826.4b

Produces and sells pharmaceutical products in South Korea and internationally.

NIBEC

Market Cap: ₩176.7b

A healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally.

Hana Pharm

Market Cap: ₩149.5b

Develops and provides various pharmaceutical products in South Korea and internationally.

Jeil Pharma Holdings

Market Cap: ₩102.5b

Manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea.

BIO-FD&CLtd

Market Cap: ₩71.9b

Develops active ingredients for anti-aging cosmetics in South Korea.

P&K Skin Research Center

Market Cap: ₩50.2b

Engages in the evaluation and research of dermatological products in South Korea.